Literature DB >> 17726029

Further evidence for two functional forms of prothrombinase each specific for either of the two prothrombin activation cleavages.

Paul Y Kim1, Michael E Nesheim.   

Abstract

Previous work showed that prothrombin derivatives cleavable only at Arg-320 (rMZ) or Arg-271 (rP2) are partial, rather than competitive, inhibitors of prothrombin activation by prothrombinase. A "ping-pong"-like model, which posits two equilibrating forms of prothrombinase, explained the inhibition pattern. The present studies were undertaken to further investigate this putative mechanism. Two models were developed, one allowing for one form of the enzyme and the other allowing for two forms. Both models also allowed channeling and ratcheting. The models were fit to full time courses of prothrombin, meizothrombin, prethrombin-2, and the B-chain. In the absence of ratcheting and channeling, neither model fits the data. In their presence, however, both models fit very well, and thus they could not be distinguished. Therefore, inhibition of rMZ activation by rP2 was studied. Inhibition was partial and the two-form model fit the data with randomly distributed residuals, whereas the one-form model did not. Initial rates of fluorescein-labeled prothrombin cleavage in the presence of various prothrombin derivatives reported by Brufatto and Nesheim (Brufatto, N., and Nesheim, M. E. (2003) J. Biol. Chem. 278, 6755-6764) were also analyzed using the two models. The two-form model fit the partial inhibition data well, whereas the one-form model did not. In addition, prothrombin at varying concentrations was activated, and subsequently, the initial rates were plotted with respect to the initial prothrombin concentration. When compared with the expected initial rates as determined by the simulation of the models, the two-form model fit the observed rates better than the one-form model. The results obtained here further support the existence of two functional forms of prothrombinase.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17726029     DOI: 10.1074/jbc.M701781200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Restricted active site docking by enzyme-bound substrate enforces the ordered cleavage of prothrombin by prothrombinase.

Authors:  Ayse Hacisalihoglu; Peter Panizzi; Paul E Bock; Rodney M Camire; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2007-09-11       Impact factor: 5.157

2.  Prothrombin activation in blood coagulation: the erythrocyte contribution to thrombin generation.

Authors:  Matthew F Whelihan; Vicentios Zachary; Thomas Orfeo; Kenneth G Mann
Journal:  Blood       Date:  2012-09-11       Impact factor: 22.113

Review 3.  The transition of prothrombin to thrombin.

Authors:  S Krishnaswamy
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

4.  Meizothrombin is an unexpectedly zymogen-like variant of thrombin.

Authors:  Harlan N Bradford; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2012-07-19       Impact factor: 5.157

5.  A revisit to the one form kinetic model of prothrombinase.

Authors:  Chang Jun Lee; Sangwook Wu; Changsun Eun; Lee G Pedersen
Journal:  Biophys Chem       Date:  2010-03-25       Impact factor: 2.352

6.  Improved hemostasis in hemophilia mice by means of an engineered factor Va mutant.

Authors:  A von Drygalski; T J Cramer; V Bhat; J H Griffin; A J Gale; L O Mosnier
Journal:  J Thromb Haemost       Date:  2014       Impact factor: 5.824

7.  Na+ binding to meizothrombin desF1.

Authors:  M E Papaconstantinou; P S Gandhi; Z Chen; A Bah; E Di Cera
Journal:  Cell Mol Life Sci       Date:  2008-11       Impact factor: 9.261

8.  Contribution of amino acid region 659-663 of Factor Va heavy chain to the activity of factor Xa within prothrombinase .

Authors:  Jamila Hirbawi; John L Vaughn; Michael A Bukys; Hans L Vos; Michael Kalafatis
Journal:  Biochemistry       Date:  2010-09-13       Impact factor: 3.162

9.  Prothrombin activation by platelet-associated prothrombinase proceeds through the prethrombin-2 pathway via a concerted mechanism.

Authors:  Laura M Haynes; Beth A Bouchard; Paula B Tracy; Kenneth G Mann
Journal:  J Biol Chem       Date:  2012-09-18       Impact factor: 5.157

10.  Prothrombin amino terminal region helps protect coagulation factor Va from proteolytic inactivation by activated protein C.

Authors:  Subramanian Yegneswaran; Phuong M Nguyen; Andrew J Gale; John H Griffin
Journal:  Thromb Haemost       Date:  2009-01       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.